Belgium
Market Access and Health Economics professional in the MedTech industry, with a focus on cardiovascular care, reimbursement, value demonstration, and patient access. Currently part of Abbott’s cardiovascular division, supporting market access, health economics, pricing, reimbursement, and stakeholder engagement activities within EMEA across medical technologies. My work is centered on translating clinical and economic value into access strategies that support adoption, reimbursement, and sustainable patient access. I bring experience across HEOR, market access strategy, pricing and reimbursement, evidence generation, payer engagement, and healthcare policy. I am particularly interested in how healthcare systems assess innovation, allocate resources, and make decisions that impact patient access to medical technologies. With an academic background from the Masters in International Healthcare Management, Economics and Policy at SDA Bocconi, focused on pharmaceuticals and medical technology, I combine system-level healthcare understanding with practical experience in MedTech access. My focus is on supporting the bridge between innovation and healthcare decision-making, ensuring that cardiovascular technologies are not only clinically meaningful, but also accessible, sustainable, and aligned with the needs of patients and healthcare systems.